Although several medications are approved to treat attention-deficit/hyperactivity disorder (ADHD), some individuals experience limited benefits from the drugs or develop side effects from their use.
Rethinking Big Data in 2024: How Healthcare Can Leverage Workforce Intelligence to Improve Care
Charlie Lougheed, CEO of Axuall The future of healthcare innovation over the next decade will be shaped by insights from clinician big data and AI,